NIOX Group Plc

NIOX Group Plc NIOX

Dividend Summary

The next NIOX Group Plc dividend will go ex in 1 month for 1p and will be paid in 2 months.
The previous NIOX Group Plc dividend was 2.5p and it went ex 8 months ago and it was paid 7 months ago.
There have not been any declared dividends recently.

Latest Dividends
Summary Previous dividend Next dividend
Status Paid Declared
Type Special Final
Per share 2.5p 1p
Declaration date 07 Jun 2023 (Wed) 26 Mar 2024 (Tue)
Ex-div date 17 Aug 2023 (Thu) 23 May 2024 (Thu)
Pay date 15 Sep 2023 (Fri) 24 Jun 2024 (Mon)

Enter the number of NIOX Group Plc shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
We have not made any dividend predictions for NIOX Group Plc
Dividend Yield Today
0.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for NIOX Group Plc
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Declared Final 26 Mar 2024 23 May 2024 24 Jun 2024 GBP 1p
Paid Special 07 Jun 2023 17 Aug 2023 15 Sep 2023 GBP 2.5p
Paid Final 31 Dec 2009 31 Dec 2009 GBP 0p
Paid Final 31 Dec 2008 31 Dec 2008 GBP 0p
Paid Final 31 Dec 2007 31 Dec 2007 GBP 0p
Paid Final 31 Dec 2006 31 Dec 2006 GBP 0p
Year Amount Change
2006 0.0p
2007 0.0p
0%
2008 0.0p
0%
2009 0.0p
0%
2010 0.0p
0%
2011 0.0p
0%
2012 0.0p
0%
2013 0.0p
0%
2014 0.0p
0%
2015 0.0p
0%
2016 0.0p
0%
2017 0.0p
0%
2018 0.0p
0%
2019 0.0p
0%
2020 0.0p
0%
2021 0.0p
0%
2022 0.0p
0%
2023 1.0p
100%

NIOX Group Plc Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
0.0%
Optimized Yield
Sign Up Required
52 Week High
0.0% on 17 April 2023
52 Week Low
0.0% on 17 April 2023
Next Ex-Div-Date Countdown
Sign Up Required

About NIOX Group Plc

Circassia develops short-course allergy therapies and a range of asthma treatments. It has a broad range of treatments in development, with many in late-stage clinical studies.  

The most advanced allergy therapy is currently undergoing phase III testing, and their asthma treatment is undergoing regulatory review.

Circassia regularly publishes its scientific progress in peer-reviewed journals, and presents results at leading scientific conferences.

Sector
Pharmaceuticals & Biotechnology
Country
United Kingdom
Share Price
£0.65 (yesterday's closing price)
Shares in Issue
422 million
Market Cap
£276mn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
none
Investor Relations URL
Sign Up Required
Home Page URL
https://www.circassia.com/
Financial Calendar URL
Sign Up Required
DividendMax Limited
DividendMax Limited